Overview of Conventional and Emerging Microbial Identification Methods (single user digital version)
- Published
- May 2018
- ISBN
- 9781942911272
- Pages
- 47
- PDA Item Number
- 18071
- Format
- PDF Single user
- Member Price
- $55.00
- Nonmember Price
- $69.00
- Government Price
- $45.00
Please sign in or become a member to purchase items from the PDA bookstore.
Here are robust discussions of microbial identifications in a new light.
This reprint from Microbial Control and Identification: Strategies, Method and Applications edited by Dona Reber and Mary Griffin demonstrate how microbial identification knowledge is a cornerstone in the concept of microbial and contamination control programs.
The complete text contains more remarkably informative chapters. For details about content, a complete table of contents and ordering information please visit: go.pda.org/MCID
Available to download. Prior to purchase please view the download instructions and Terms of Usage
Format: PDF (1 file 1.70 MB)
Table of Contents
Table of Contents:
- Introduction
- Microbial Identification: What Method to Use
- Isolation of Microorganisms in Pure Culture
- Methods for Characterization and Preliminary Screening
- Phenotypic Methods for Microbial Identification
- Fatty Acid Analysis Using the Midi Sherlock®
- MALDI-TOF
- Genotypic Methods for Bacterial Identification
- Ribotyping
- Identification of Fungi
- Molecular Methods for Fungal Identification
- Use of Contract Laboratories for Microbial Identification
- Conclusion
- References
About the Authors
About the Authors
Frank E. Matos, M.S. is a pharmaceutical microbiologist with over 27 years of experience in Quality Control Microbiology, sterility assurance, method development, validation and leading technical groups. In his current role as Director of Sterility Assurance at SOFIE, he is responsible for overseeing the Microbiology and microbial control program for multiple aseptic processing facilities. He is the former QC Manager of Science and Technology at Sanofi Genzyme in Framingham, MA. In said role he led a technical group engaged in assay validation and implementation of best practices and latest technologies for QC Microbiology. Under his leadership the S&T team was responsible for multiple validation projects and implementation of advanced technologies for microbial identification based on DNA sequencing and mass spectrometry. Prior to joining Sanofi Genzyme in 2010, Frank led the Assay Validation team at the Wyeth facility in Pearl River, NY. At Wyeth he led the validation activities of multiple assays including sterility testing, kinetic endotoxin and rapid bioburden. From 1999 to 2004 Frank worked as an independent consultant and founded a contractvalidation company that focused on QC Microbiology and sterilization cycle development/validation. He holds a M.S. degree in Medical Microbiology and Immunology from the University of Oklahoma College of Medicine.
Jennifer Reyes, M.S. is the QC Technical Support Manager for the Raw Materials, Microbiology and Compendia group at Bristol-Myers Squibb where she is responsible for all raw materials supporting clinical and commercial campaigns. Jennifer has more than 15 years of microbial experience with in the biotech and pharmaceutical industries. Formerly a Scientist in the Quality Control Science and Technology group at Genzyme (Framingham,MA) she focused on the development, validation and implementation of new/rapid microbiological technologies and existing compendial methodologies. Prior to joining Sanofi Genzyme, Jennifer was a keymember of the Microbial Technology Assessment team at Pfizer Inc., (Groton, CT) focusing on Rapid Microbiological Method (RMM) development. She received her Master's degree in Microbiology from the University of Rhode Island in 2001.